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PERSPECTIVE
Endogenous neural progenitor cells in 
the repair of the injured spinal cord 
Stem cell treatments, and in particular, stem cell transplants have 
been identified as potential therapeutic strategies for a range of 
neurodegenerative and acquired conditions of the central nervous 
system (CNS). Stem cell transplants are seen as a way of replacing 
lost neurons, or providing a cellular environment that is more 
permissible for axon and cell regeneration. An alternate strategy 
to transplantation of exogenous stem cells is the recruitment and 
manipulation of endogenous neural progenitor cells (NPC). NPCs 
exist in the spinal cord and have been shown to proliferate, migrate 
and differentiate in response to injury (Mothe and Tator, 2005; Me-
letis et al., 2008; Hamilton et al., 2009). NPCs may have a wider role 
than previously thought and it has been reported that NPCs also 
engage in ‘cross talk’ with immune cells and may be able to modu-
late the inflammatory response following injury. Our research has 
focussed on determining the exact timing and location of NPC 
activation after injury. It is clear that there will be a critical window 
of opportunity to implement a treatment that harnesses the NPC 
response to spinal cord injury (SCI), and that this must occur be-
fore the full cascade of inflammation has been initiated.  
Traumatic SCI causes the destruction of neuronal and glial cells 
leading to the disruption of sensory and/or motor functions. To 
date, there is no known cure for SCI. There is evidence that prim-
itive vertebrates such as the teleost fish (Zupanc and Sîrbulescu, 
2012) and lizards (Fisher et al., 2012) are able to regenerate spinal 
tissue after trauma resulting in extensive axonal regrowth and func-
tional recovery. In these animals it is the recruitment of NPCs that 
plays a major role in the regeneration. NPCs are the precursor to all 
of the neural cells - neurons, astrocytes and oligodendrocytes. Fol-
lowing injury, including axonomy, in the lower vertebrates several 
genes and structural proteins such as Sox1 and fibroblast growth 
factor-2 are upregulated (Ferretti et al., 2001) which drives the re-
generation of neuronal cells and eventually leads to an elongation 
and regrowth of the spinal cord. 
Vertebrate mammals have lost this capacity to regrow nervous 
tissue following injury even though NPCs are found lining of the 
central canal of the spinal cord. During non-pathological condi-
tions, they remain in a quiescent state in the ependymal layer and 
demonstrate minimal proliferation activity to maintain the homeo-
stasis of neural cells in the spinal cord (Hamilton et al., 2009). In 
rodent models NPCs are observed to increase proliferation and dif-
ferentiation significantly and then migrate to the lesion area follow-
ing a SCI (Mothe and Tator, 2005; Meletis et al., 2008). However, in 
rodent models, migrating NPCs are more likely to differentiate into 
astrocytes forming the glial scar (Mothe and Tator, 2005). While 
differentiation into all three lineages can occur in vitro under the 
correct growth conditions, no spontaneous differentiation of NPCs 
into neurons in vivo has been documented. One study by Guo et al. 
(2014) induced the transcription factor Sox11 via a lentiviral vector 
in a mouse SCI model, and demonstrated that it is possible to dif-
ferentiate NPCs into neurons in vivo. In ependymal cells, the acti-
vation of Sox11 is associated with an upregulation of Nestin, a type 
VI intermediate filament protein found predominately in NPCs in 
the developing or injured spinal cord (Tzeng, 2002). Consequently 
these cells have the potential to be manipulated in situ, offering a 
novel approach to restore the injured spinal cord and much effort is 
made to identify the response of NPCs to traumatic SCI in relation 
to location, time and inflammation.
Activation of endogenous neural progenitor cells throughout the 
neuroaxis: Following injury to the CNS, we have shown that there 
is an increase in Nestin reactivity beyond the lesion site in humans 
(Cawsey et al., 2015). In our rat model of T10 contusion injury an 
increased expression of Nestin was also observed both caudally and 
rostrally to the injury site (Figure 1A, B). This suggests a whole 
spinal cord response to a discrete lesion localized to the T10 region 
of the spinal cord. The response may be occurring due to chemical 
signals, such as inflammatory cytokines, travelling through the cere-
brospinal fluid (CSF) and interacting with the quiescent endogenous 
NPCs located beyond the lesion site. Exactly why NPCs are reacting 
distal to the injury site is unknown at this stage, although it is possi-
ble that the ependymal cells have a surveillance role involved in ‘sam-
pling’ the CSF in the same way in which tanycytes lining the third 
ventricle are thought to communicate with the hypothalamus. Our 
studies have used the immunohistochemical expression (Figure 1C–
E) of Nestin as a marker of endogenous NPCs. Following SCI, nestin 
positive ependymal cells have a very similar morphology to that 
described for tanycytes, with long basal processes, and interactions 
with blood vessels, however, whether they have similar functions in 
regenerating the CNS during an injury is difficult to determine since 
endogenous NPCs are not a homogenous cell population.
Modulation of immune responses by neural progenitor cells: 
While the majority of studies have classically targeted endogenous 
NPCs as a structural or cell replacement treatment after SCI, anoth-
er significant role for NPCs in the post-injury microenvironment 
is emerging. That is the role of immune responses within the CNS 
following trauma. In recent years, a high degree of interaction and 
‘cross-talk’ has been highlighted between the nervous and immune 
systems (Cusimano et al., 2012). The term ‘therapeutic plasticity’ 
was coined to describe NPCs emerging abilities to modulate their 
surrounding environment, as well as respond to its cues, and in-
struct other innate and immune cells after trauma (Cusimano et 
al., 2012). The beneficial effects of NPCs as immune modulators 
include secreting a variety of neurotrophic molecules, responding 
to the cues from the microenvironment, as well as instructing the 
innate immune cells via cellular junction coupling between NPCs 
and active phagocytes including macrophages and microglia. A 
recent study highlighted the ability of transplanted NPCs to survive 
undifferentiated at the peri-lesion area, in order to modulate the 
expression of inflammatory gene transcripts (Cusimano et al., 2012). 
As a consequence, the number of pro-inflammatory macrophages 
was reduced at the lesion area at 7 days post-injury, with the ultimate 
results of limited secondary injury and improved healing. There is 
also mounting evidence to suggest that NPCs in the CNS can switch 
to a ‘chaperone’ phenotype to assist in tissue repair via inherent reg-
ulatory and protective activities (Hauwel et al., 2005). This is likely 
mediated by growth and trophic factors such as brain-derived neu-
rotrophic factor (BDNF), members of the nerve growth factor (NGF) 
family and the prevalent cytokines in the microenvironment. This 
releasing and receiving of effector molecules place greater emphasis 
on the synergy between NPCs and immune cells. From this, the en-
dogenous NPCs may also be manipulated to engage in modulation 
of immune responses as a reparative strategy for SCI.
Window of opportunity to manipulate endogenous neural pro-
genitor cells: There will be a valuable window of opportunity, within 
a relatively short time following injury, to manipulate endogenous 
NPCs as a novel approach for SCI repair. We have shown that en-
dogenous NPCs at the central canal are activated within 1 week, 
and most likely within 24 hours, after SCI in a rat model, while the 
astrogliosis (GFAP reactivity) starts forming at the lesion area from 1 
week (Mao et al., 2016). These activated NPCs are thought to induce 
astrogliogenesis spontaneously, contributing to the formation of 
astroglial scar at the lesion area. Therefore, therapeutic interventions 
should be conducted to promote neurogenesis, or reduce inflam-
mation, prior to the astroglial differentiation in order to build up 
functional nerve tissue instead of astroglial scar. It is postulated that 
a reduction in astrogliosis with a simultaneous increased survival of 
neurons is beneficial for spinal cord repair and functional recovery. 
In addition, early interventions to manipulate endogenous NPCs 
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may be able to circumvent the deleterious chronic inflammatory 
responses occurring. The initial inflammatory response at the acute 
phase of SCI is required, however the persistent pro-inflamma-
tory response is ultimately detrimental. We have shown a robust 
pro-inflammatory response within the first week following a SCI 
involving neutrophils, peaking at 24 hours. This is followed by a 
significant influx of macrophages, predominantly M1 like, peaking 
at 1 week. It is the continuation of these responses that becomes 
detrimental to recovery and an early modulation by NPCs will as-
sist in alleviating this as well as promoting neuronal survival.
Summary and conclusions: There is rising evidence indicating that 
manipulation of the endogenous NPCs could be an innovative plat-
form for the treatment of acute SCI. The use of endogenous NPCs 
has the advantages of avoiding risky surgical procedures, bypassing 
invasive delivery systems, eliminating tumorigenesis and reducing a 
rejective immune response over transplantation of stem/progenitor 
cells. It also negates ethical concerns regarding the use of embryonic 
stem cells or stem cells from alternate sources that might delay the 
application of cell grafts for SCI patients.  
However, our research, and that of others, highlights the need for 
further investigation regarding spinal cord NPCs. What is their nor-
mal role in the spinal cord? How can a treatment be targeted at the 
local injury site only, not the entire CNS? What are the characteristics 
of the endogenous NPCs in the injured spinal cord, especially in 
relation to inflammatory responses? What are the sub-populations 
of cells in the ependymal layer of the central canal and what is their 
contribution to injury response? Further research needs be conducted 
to develop a viable strategy to manipulate the endogenous NPCs into 
neuronal termination to repair the injured spinal cord, and to modu-
late the inflammatory response to reduce ongoing tissue damage.  
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Figure 1 Nestin expression throughout the neuroaxis following a contusion injury at T10 in a rat spinal cord. 
(A) A schematic of the central nervous system with a spinal cord injury (SCI; red). The blue structure represents the neuroaxis consisting of the 
ventricular systems of the brain and the central canal of the spinal cord. Nestin immunoreactivity was measured at the median eminence of the 
third ventricle (3V), cervical enlargement (CE), 2.25 mm rostral to the epicentre of lesion (RL), the T10 epicentre of lesion (Epi), 2.25 mm caudal 
to the epicentre of lesion (CL) and lumbar enlargement (LE). (B) Fold change of Nestin immunoreactivity following spinal cord injury throughout 
the neuroaxis compared to the sham. (C) Fluorescent immunohistochemistry demonstrated the Nestin positive cells (red) at the ependymal area of 
the spinal cord while the nuclei were counterstained by Hoechst (blue) at 2.25 mm rostral to the epicentre of the lesion. (D) Fluorescent immuno-
histochemistry demonstrated the glial fibrillary acidic protein positive cells (green) at the ependymal area of the spinal cord while the nuclei were 
counterstained by Hoechst (blue) at 2.25 mm rostral to the epicentre of lesion. (E) The merged image of Nestin (red) and glial fibrillary acidic pro-
tein (green) staining at the ependymal layer on rat spinal cord transverse sections at 2.25 mm rostral to the epicentre of lesion. Nestin positive cells 
at the central canal did not express glial fibrillary acidic protein. Scale bars: 25 μm. t-test, injury vs. sham, *P < 0.05, **P < 0.01, ***P < 0.001.
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